Chemotherapy for aggressive or anaplastic high grade oligodendrogliomas and oligoastrocytomas: Better than a salvage treatment

British Journal of Neurosurgery

Volumn 12, Issue 3, 1998, Pages 217-222

  Bouffet, E ^a,c   Jouvet, A ^b   Thiesse, P ^a   Sindou, M ^b  

^a CENTRE LÉON BÉRARD   (France)

^b HÔPITAL NEUROLOGIQUE   (France)

^c INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Anaplastic oligodendroglioma; Chemotherapy; Multidisciplinary approach; Nitrosourea; Oligoastrocytomas

Indexed keywords

ONDANSETRON; PROCARBAZINE; VINCRISTINE;

ADULT; AGED; ARTICLE; ASTROCYTOMA; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HEMATOLOGIC DISEASE; HUMAN; INFECTION COMPLICATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; OLIGODENDROGLIOMA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROGNOSIS; RASH; SEIZURE; SEPTICEMIA;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASTROCYTOMA; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; CRANIAL IRRADIATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LOMUSTINE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OLIGODENDROGLIOMA; RADIOTHERAPY, ADJUVANT; SALVAGE THERAPY; TREATMENT OUTCOME; VINCRISTINE;

EID: 0031805091     PISSN: 02688697     EISSN: None     Source Type: Journal    
DOI: 10.1080/02688699845023     Document Type: Article

References (21)

1. Cairncross JG, Macdonald DR. Successful chemotherapy for recurrent malignant oligodendroglioma. Ann Neurol 1988;23:360-4.
2. Macdonald-DR, O'Brien-RA, Gilbert-JJ, CairncrossJG. Metastatic anaplastic oligodendroglioma. Neurology 1989;39:1593-6.
3. Macdonald DR, Caspar LE, Cairncross JG. Successful chemotherapy for newly diagnosed aggressive oligodendroglioma. Ann Neurol 1990 27:573-4.
4. Brown M, Cairncross JG, Vick NA. Differential response to recurrent oligodendrogliomas versus astrocytomas to intravenous melphalan. Neurology 1990;40:397-8 (Abstr.).
5. Hachinski-V. Are anaplastic oligodendrogliomas chemosensitive? Arch Neurol 1991;48:227.
6. Glass J, Hochberg FH, Gruber ML, Louis DN, Smith D, Rattner B. The treatment of oligodendrogliomas and mixed oligodendroglioma-astrocytoma with PCV chemotherapy. J Neurosurg 1992;76:741-5.
7. Cairncross JG, Macdonald DR, Ludwin S, Lee D, Cascino T, Buckner J, et al. Chemotherapy for anaplastic oligodendroglioma. J Clin Oncol 1994;12:2013-21.
8. Levin VA, Edwards MS, Wright DC, Seager ML, Pischer-Shimberg TP, Townsend JJ, et al. Modified procarbazine, CCNU and vincristine (PCV-3) combination chemotherapy in the treatment of malignant brain tumors. Cancer Treat Rep 1980;64:237-41.
9. Kleihues P, Burger PC, Scheithauer BW. Oligodendroglial tumours. In Kleihues P, Burger PC, Scheithauer BW, (eds) Histological Typing of Tumours of the Central Nervous System, 2nd edn. Berlin: Springer Verlag, 1993:13-14.
10. Herpers MJHM, Budka H. Glial fibrillary acidic protein (GFAP) in oligodendroglial tumors: gliofibrillary oligodendroglioma and transitional oligodendroglioma as subtypes of oligodendroglioma. Acta Neuropathol (Berl) 1984;64:265-72.
11. Shaw EG, Scheithauer BW, O'Fallon JR, Talezaar HD, Davis DH. Oligodendroglioma: the Mayo Clinic experience. J Neurosurg 1992;76:428-34.
12. Smith MT, Ludwig CL, Godfrey AD, Armbrustmacher VW. Grading of oligodendrogliomas. Cancer 1983;52:2107-14.
13. Wilkinson IMS, Anderson JR, Holmes AE. Oligodendroglioma: an analysis of 42 cases. J Neurol Neurosurg Psychiatry 1987;50:304-12.
14. Bullard DE, Rawlings CE, Phillips B, Cox EB, Schold SC, Burger PC, et al. Oligodendroglioma. An analysis of the value of radiation therapy. Cancer 1987;60:2179-88.
15. Nijjar TS, Simpson WJ, Gadalla T, McCartney M. Oligodendroglioma: the Princess Margaret Hospital experience (1958-1984). Cancer 1993;71:4002-6.
16. Kyritsis AP, Yung WKA, Bruner J, Gleason MJ, Levin VA, Sawaya R, et al. The treatment of anaplastic oligodendrogliomas and mixed gliomas. Neurosurgery 1993;32:365-71.
17. Kim L, Hochberg FH, Thornton AF, Harsh GR, Patel H, Finkelstein D, et al. Procarbazine, lomustine, and vincristine (PCV) chemotherapy for grade III and IV oligoastrocytomas. J Neurosurg 1996;85:602-7.
18. Mason WP, De Angelis LM. Procarbazine, CCNU, vincristine (PCV) chemotherapy for benign oligodendroglioma (Abstract). Neurology 1994;44 (suppl 2): Abstr. 262
19. Coyle T, Bushunow P, Winfield J, Wright J, Graziano S. Hypersensitivity reactions to procarbazine with mechlorethamine, vincristine, and procarbazine chemotherapy in the treatment of glioma. Cancer 1992;69:2532-40.
20. Imperato JP, Paleologos NA, Vick NA. Effects of treatment on long-term survivors with malignant astrocytomas. Ann Neurol 1990;28:818-22.
21. Lesser GJ, Grossman S. The chemotherapy of high grade astrocytomas. Sem Oncol 1994;21:220-35.